PTPA and hepatocellular carcinoma: Notably, ALDOB can interact with AKT1 and inhibit AKT1 phosphorylation by recruiting PP2A in HCC.[17] Our co‐IP results in HCC cells also confirmed that ALDOB can bind to AKT1 (Figure 4E; Figure S6E, Supporting Information).